Morgan Stanley 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-12 4:18 pm Sale |
2021-09-30 | 13G | Aprea Therapeutics, Inc. APRE |
MORGAN STANLEY MS |
9,248 0.900% |
-44,372 (-82.75%) |
Filing |
| 2021-03-24 5:13 pm Purchase |
2021-03-15 | 13G | Aprea Therapeutics, Inc. APRE |
MORGAN STANLEY MS |
53,621 5.100% |
53,621 (New Position) |
Filing |